Archive: 26/07/2011

New therapy for HER2-positive breast cancer developed

Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.

Jul 26, 2011
popularity0 comments 0

Targeting PTEN may prevent skin cancer

Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation, a known risk factor for non-melanoma skin cancer, according to a study published in Cancer ...

Jul 26, 2011
popularity0 comments 0